Skip to main content
. 2025 May 23;16:1573098. doi: 10.3389/fimmu.2025.1573098

Table 2.

Tumor response.

Overall RECIST 1.1 p mRECIST p
LenHAP (n=108) BevHAP (n=108) LenHAP (n=108) BevHAP (n=108)
CR 0 0 10 (9.3%) 4 (3.7%) 0.097
PR 67 (62.0%) 53 (49.1%) 0.055 80 (74.1%) 70 (64.8%) 0.14
SD 35 (32.4%) 43 (39.8%) 0.26 12 (11.1%) 22 (20.4%) 0.062
PD 6 (5.6%) 11 (10.2%) 0.21 6 (5.6%) 11 (10.2%) 0.21
NA 0 1 (0.9%) 1 0 1 (0.9%) 1
ORR 67 (62.0%) 53 (49.1%) 0.055 90 (83.3%) 74 (68.5%) 0.011
DCR 102 (94.4%) 96 (88.9%) 0.14 102 (94.4%) 96 (88.9%) 0.14
Intrahepatic RECIST 1.1 p mRECIST p
LenHAP (n=108) BevHAP (n=108) LenHAP (n=108) BevHAP (n=108)
CR 0 0 24 (22.2%) 11 (10.2%) 0.016
PR 72 (66.7%) 54 (50%) 0.013 72 (66.7%) 63 (58.3%) 0.21
SD 34 (31.5%) 46 (42.6%) 0.091 10 (9.3%) 26 (25.9%) 0.003
PD 2 (1.9%) 7 (6.5%) 0.17 2 (1.9%) 7 (6.5%) 0.17
NA 0 1 (0.9%) 1 0 1 (0.9%) 1
ORR 72 (66.7%) 54 (50%) 0.013 96 (88.9%) 74 (68.5%) <0.001
DCR 106 (98.1%) 100 (92.6%) 0.052 106 (98.1%) 100 (92.6%) 0.052